| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |